GU Cancers 2024 | What role does FDG-PET have in managing bladder cancer?

Antonio Cigliola, MD, IRCCS San Raffaele Hospital, Milan, Italy, comments on the role of fluoro-deoxy-glucose positron emission tomography (FDG-PET) in the management of urothelial carcinoma. In addition to assessing lymph node involvement, FDG-PET can evaluate responses after neoadjuvant treatment in a functional manner. This interview took place at the ASCO GU Cancers Symposium 2024 in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.